| Literature DB >> 29681148 |
Shani Zeeli1, Tehilla Weill2, Efrat Finkin-Groner2, Corina Bejar2, Michal Melamed2, Svetlana Furman1, Michael Zhenin1, Abraham Nudelman1, Marta Weinstock2.
Abstract
We describe the preparation and evaluation of novel indoline derivatives with potent antioxidant and anti-inflammatory activities for the treatment of pathological conditions associated with chronic inflammation. The indolines are substituted at position 1 with chains carrying amino, ester, amide, or alcohol groups, and some have additional substituents, Cl, MeO, Me, F, HO, or BnO, on the benzo ring. Concentrations of 1 pM to 1 nM of several compounds protected RAW264.7 macrophages against H2O2 induced cytotoxicity and LPS induced elevation of NO, TNF-α, and IL-6. Several derivatives had anti-inflammatory activity at 1/100th of the concentration of unsubstituted indoline. Four compounds with ester, amine, amide, or alcohol side chains injected subcutaneously in mice at a dose of 1 μmol/kg or less, like dexamethasone (5.6 μmol/kg) prevented LPS-induced cytokine elevation in the brain and peripheral tissues. Subcutaneous injection of 100 μmol/kg of these compounds caused no noticeable adverse effects in mice during 3 days of observation.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29681148 DOI: 10.1021/acs.jmedchem.8b00001
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446